loading

Phio Pharmaceuticals Corp Azioni (PHIO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - 0.231
Operating Expenses
1.16%
2.534
2.505 2.309 1.872 1.674
Operating Income/Loss
1.16%
-2.534
-2.505 -2.309 -1.872 -1.674
Income/Loss From Continuing Operations Before Tax
0.88%
-2.371
-2.392 -2.166 -1.769 5.755
Income/Loss From Continuing Operations After Tax
0.88%
-2.371
-2.392 -2.166 -1.769 -1.626
Net Income/Loss
0.88%
-2.371
-2.392 -2.166 -1.769 -1.626
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
79.43%
1.1249
5.4686 4.7949 4.3073 0.1166
Basic Earnings Per Share
65.91%
-0.15
-0.44 -0.45 -0.41 -0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):